Unknown

Dataset Information

0

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.


ABSTRACT: PURPOSE:To develop a prognostic model and cytogenetic risk classification for previously treated patients with chronic lymphocytic leukemia (CLL) undergoing reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT). EXPERIMENTAL DESIGN:We performed a retrospective analysis of outcomes of 606 patients with CLL who underwent RIC allogeneic HCT between 2008 and 2014 reported to the Center for International Blood and Marrow Transplant Research. RESULTS:On the basis of multivariable models, disease status, comorbidity index, lymphocyte count, and white blood cell count at HCT were selected for the development of prognostic model. Using the prognostic score, we stratified patients into low-, intermediate-, high-, and very-high-risk [4-year progression-free survival (PFS) 58%, 42%, 33%, and 25%, respectively, P < 0.0001; 4-year overall survival (OS) 70%, 57%, 54%, and 38%, respectively, P < 0.0001]. We also evaluated karyotypic abnormalities together with del(17p) and found that del(17p) or ?5 abnormalities showed inferior PFS. Using a multivariable model, we classified cytogenetic risk into low, intermediate, and high (P < 0.0001). When the prognostic score and cytogenetic risk were combined, patients with low prognostic score and low cytogenetic risk had prolonged PFS (61% at 4 years) and OS (75% at 4 years). CONCLUSIONS:In this large cohort of patients with previously treated CLL who underwent RIC HCT, we developed a robust prognostic scoring system of HCT outcomes and a novel cytogenetic-based risk stratification system. These prognostic models can be used for counseling patients, comparing data across studies, and providing a benchmark for future interventions. For future study, we will further validate these models for patients receiving targeted therapies prior to HCT.

SUBMITTER: Kim HT 

PROVIDER: S-EPMC6697588 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.

Kim Haesook T HT   Ahn Kwang Woo KW   Hu Zhen-Huan ZH   Davids Matthew S MS   Volpe Virginia O VO   Antin Joseph H JH   Sorror Mohamed L ML   Shadman Mazyar M   Press Oliver O   Pidala Joseph J   Hogan William W   Negrin Robert R   Devine Steven S   Uberti Joseph J   Agura Edward E   Nash Richard R   Mehta Jayesh J   McGuirk Joseph J   Forman Stephen S   Langston Amelia A   Giralt Sergio A SA   Perales Miguel-Angel MA   Battiwalla Minoo M   Hale Gregory A GA   Gale Robert Peter RP   Marks David I DI   Hamadani Mehdi M   Ganguly Sid S   Bacher Ulrike U   Lazarus Hillard H   Reshef Ran R   Hildebrandt Gerhard C GC   Inamoto Yoshihiro Y   Cahn Jean-Yves JY   Solh Melhem M   Kharfan-Dabaja Mohamed A MA   Ghosh Nilanjan N   Saad Ayman A   Aljurf Mahmoud M   Schouten Harry C HC   Hill Brian T BT   Pawarode Attaphol A   Kindwall-Keller Tamila T   Saba Nakhle N   Copelan Edward A EA   Nathan Sunita S   Beitinjaneh Amer A   Savani Bipin N BN   Cerny Jan J   Grunwald Michael R MR   Yared Jean J   Wirk Baldeep M BM   Nishihori Taiga T   Chhabra Saurabh S   Olsson Richard F RF   Bashey Asad A   Gergis Usama U   Popat Uday U   Sobecks Ronald R   Alyea Edwin E   Saber Wael W   Brown Jennifer R JR  

Clinical cancer research : an official journal of the American Association for Cancer Research 20190628 16


<h4>Purpose</h4>To develop a prognostic model and cytogenetic risk classification for previously treated patients with chronic lymphocytic leukemia (CLL) undergoing reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT).<h4>Experimental design</h4>We performed a retrospective analysis of outcomes of 606 patients with CLL who underwent RIC allogeneic HCT between 2008 and 2014 reported to the Center for International Blood and Marrow Transplant Research.<h4>Result  ...[more]

Similar Datasets

| EGAC00001002536 | EGA